# Mark Fleming, MD – FDA Inspection, May 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/mark-fleming-md/4a453fda-3ccc-40bd-b6ad-29664c6b9f21
Source feed: FDA_Inspections

> FDA inspection 1015616 of Mark Fleming, MD, May 03, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015616
- Company Name: Mark Fleming, MD
- Inspection Date: 2017-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Wilfred A. Darang](https://www.keypedia.com/people/wilfred-a-darang/f0f1e653-891d-47d6-82e3-5ce40a5d3635)

Company: https://www.keypedia.com/companies/mark-fleming-md/4cfb18d3-7852-41d6-a5f0-53f6f684fe33

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
